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Proteins, particularly viral proteins, can bemultifunc-
tional, but the mechanisms behind multifunctionality
are not fully understood. Here, we illustrate through
multiple crystal structures, biochemistry, and cellular
microscopy that VP40 rearranges into different struc-
tures, each with a distinct function required for the
ebolavirus life cycle. A butterfly-shaped VP40 dimer
traffics to the cellular membrane. Once there, elec-
trostatic interactions trigger rearrangement of the
polypeptide into a linear hexamer. These hexamers
construct a multilayered, filamentous matrix struc-
ture that is critical for budding and resembles tomo-
grams of authentic virions. A third structure of VP40,
formed by a different rearrangement, is not involved
in virus assembly but instead uniquely binds RNA to
regulate viral transcription inside infected cells.
These results provide a functional model for ebolavi-
rus matrix assembly and the other roles of VP40 in
the virus life cycle and demonstrate how a single
wild-type, unmodified polypeptide can assemble
into different structures for different functions.
INTRODUCTION
Ebolaviruses cause severe hemorrhagic fever with up to 90%
lethality and are considered potential biological weapons
(Bwaka et al., 1999; Kuhn, 2008). There are five antigenically
distinct ebolaviruses, each named after the outbreak location
in which they were first discovered. Of these, the two most com-
mon are Ebola virus and Sudan virus (Kuhn et al., 2011; Adams
et al., 2012). Ebolaviruses encode just seven genes and are
distinguished by their pleomorphic filamentous morphology(Kuhn, 2008). Ebolaviruses assemble and bud from the cell
membrane in a process driven by the viral matrix protein VP40
(Harty et al., 2000; Panchal et al., 2003). VP40 alone is sufficient
to assemble and bud filamentous virus-like particles (VLPs) from
cells (Geisbert and Jahrling, 1995; Johnson et al., 2006; Noda
et al., 2002).
The first crystal structure of VP40 suggested that this protein is
monomeric (Dessen et al., 2000a, 2000b). The structure revealed
that VP40 contains distinct N- and C-terminal domains (NTDs
and CTDs, respectively), both essential for trafficking to and
interaction with the membrane (Harty, 2009; Jasenosky et al.,
2001). The limited number of contacts observed between the
NTD and CTD suggests that they are tenuously connected and
could separate to assemble a different structure (Dessen et al.,
2000b; Gomis-Ru¨th et al., 2003). Indeed, when VP40 is incu-
bated with urea and RNA or liposomes, conformational changes
occur, and the NTD then drives the assembly of RNA-binding
ring structures (Harty, 2009). A crystal structure of a VP40 ring
was solved by expressing the VP40 NTD alone. In the structure,
eight VP40 NTDs assemble into a ring with each NTD bound to
an RNA trinucleotide (Gomis-Ru¨th et al., 2003).
Currently, the VP40 ring and the interfaces by which it assem-
bles provide the only known structural model of how VP40 might
assemble the ebolavirus matrix. However, these rings are
observed only in infected cells, not in mature purified ebolavi-
ruses (Gomis-Ru¨th et al., 2003), suggesting the ring structure
is not involved in matrix assembly. Instead, the RNA-binding
VP40 rings likely play a critical, but currently undefined role
inside the infected cell (Gomis-Ru¨th et al., 2003; Hoenen et al.,
2010a).
Despite the wealth of structural and biochemical data, no
cohesive model exists for how the ebolavirus matrix is assem-
bled. It is currently unclear which structure of VP40 migrates
to the cell membrane and how that structure is triggered to
further oligomerize into the viral matrix. Although RNA binding
by VP40 is critical to the viral life cycle (Hoenen et al., 2005),Cell 154, 763–774, August 15, 2013 ª2013 Elsevier Inc. 763
the exact role of the VP40 RNA-binding ring has remained
elusive. In addition and perhaps most significantly, the struc-
tural arrangement of VP40 within the ebolavirus matrix remains
unknown. Here, we set out to provide a structurally and biolog-
ically supported model of VP40-driven matrix assembly and
elucidate the different roles played by VP40 in the ebolavirus
life cycle.
We first purified VP40 and determined that it is a dimer in so-
lution, not a monomer. We then determined multiple crystal
structures of dimeric VP40, from Ebola virus and Sudan virus,
revealing a conserved dimeric interface. Targeted mutagenesis
of the dimer interface abolishes trafficking of VP40 to the cell
membrane and budding of VLPs, suggesting that the VP40 dimer
is a critical precursor of the viral matrix. We next analyzed a
conserved CTD-to-CTD interface by which VP40 dimers are
linked together in crystals. Structure-based mutagenesis of the
CTD-to-CTD interface abolishes assembly and budding of vi-
rus-like particles, but not trafficking to or interactions with the
membrane. Thus, assembly of VP40 dimers via CTD interactions
likely represents a critical step in matrix assembly.
We next turned our attention to understanding how the VP40
dimer interacts with the membrane and conformational changes
believed to occur at the membrane and be important to matrix
assembly. Previous work has demonstrated that electrostatic
interactions between the VP40 CTD and the membrane are
likely important to matrix assembly (Adu-Gyamfi et al., 2012;
Ruigrok et al., 2000; Scianimanico et al., 2000). Through tar-
geted mutagenesis, we identified a conserved basic patch in
the CTD that mediates both membrane interaction and subse-
quent matrix assembly events. An electrostatic mimic of the
membrane was found to trigger conformational rearrangement
of VP40 dimers into a linear hexameric assembly. In the crystal
structure of this assembly, VP40 hexamers also connect into
continuous filaments via the conserved CTD interactions. We
propose that the VP40 hexamer structure represents a building
block of the flexible, filamentous ebolavirus matrix. Our hexame-
ric VP40 structure suggests that VP40 assembles into a multi-
layered matrix along the membrane, which is consistent with
recent electron tomographic analysis of filoviruses in scale,
dimension, and layered construction (Beniac et al., 2012; Bharat
et al., 2011).
We also determined that the VP40 RNA-binding ring structure,
although derived from the VP40 dimer, is not involved in or
required for matrix assembly and budding. Instead, we show
that the VP40 ring plays a distinct and critical role in regulation
of viral transcription inside infected cells and that this function
is dependent on its unique RNA-binding capability.
Taken together, our results illustrate that the highly plastic
VP40 polypeptide is able to rearrange itself into distinct struc-
tural assemblies. Each of these distinct structures is assembled
by the unmodified wild-type polypeptide, and each structure is
required for a separate and essential function in the virus life
cycle: a dimeric precursor critical for cellular trafficking, a hex-
americ structural component for the viral matrix assembly, and
a nonstructural RNA-binding ring structure essential for regu-
lating viral transcription. Thus, the physical plasticity inherent in
VP40 demonstrates how a structural rearrangement can expand
the functional repertoire of a single viral gene.764 Cell 154, 763–774, August 15, 2013 ª2013 Elsevier Inc.RESULTS
Ebolavirus VP40 Is a Dimer in Solution
Three constructs of VP40 were expressed without fusion part-
ners, purified, and subjected to size-exclusion chromatography
and multiangle light scattering (SEC-MALS). These included
wild-type full-length Ebola virus VP40 (WT-VP40E) and Ebola
and Sudan virus VP40 with a deletion of 43 residues from the
disordered N terminus in order to improve crystal diffraction
(VP40EDN and VP40SDN, respectively) (Figure 1A). All three
VP40 proteins consistently elute from size-exclusion columns
as dimers and maintain molecular weights consistent with a
dimer via SEC-MALS analysis, a more sensitive method for
accurate molecular weight determination than size-exclusion
chromatography alone (Wyatt, 1998) (Figure S1 available online).
This result is in contrast to previous work in which VP40 (also
containing an N-terminal deletion of 30 residues) was character-
ized as a monomer (VP40EM) (Dessen et al., 2000a, 2000b).
Crystal Structures of Sudan and Ebola Virus VP40
Identify the Dimeric Interface of Ebolavirus VP40
The VP40SDN protein crystallizes in the space groupC2with one
protomer in the crystallographic asymmetric unit (ASU) and
diffracts to 1.8 A˚ resolution. The VP40EDN protein crystallizes in
the space group P62 with four protomers in the ASU and
diffracts to 3.1 A˚ resolution. In all of these crystal structures, the
overall proteinarchitecture remainsconservedwith thepreviously
determined VP40EM (Dessen et al., 2000b): the NTD contains a b
sandwich decorated by four small a helices, whereas the CTD
contains some disordered loop structure that links two small b
sheets and two a helices. Here, we detail the structure of the
dimeric interface conserved in the crystal structures (Figure 1).
There is one protein-protein interface that is completely
conserved throughout crystals of VP40EDN and VP40SDN, sug-
gesting that it assembles the in-solution dimer. The interface
appears between the NTDs of two VP40 protomers and buries
1,500–1,700 A˚2 of molecular surface, depending on the viral spe-
cies of the VP40 (Figures 1B). Although not previously described,
this dimeric interface is also conserved between symmetry-
related protomers in the crystal packing of VP40EM (Dessen
et al., 2000b). Overall, the dimers are structurally conserved
with a root-mean-square deviation (rmsd) of 0.45 to 0.88 A˚
(Figure S2).
The VP40 dimeric interface involves residues 52–65 and 108–
117, which encompass two a helices (residues 61–65 and 108–
116). Interactions within the VP40 dimeric interface have limited
hydrogen bonding and are primarily hydrophobic in nature. The
hydrophobic network in the dimer interface involves residues
A55, H61, F108, T112, A113, M116, and L117, of which L117
appears to be of central importance. L117 extends into a hydro-
phobic pocket formed by residues H61, A55, M116, and F108 in
the opposing subunit and appears to lock the VP40 protomers
together into a dimer (Figure 1C).
The Dimer Interface Is Essential for Matrix Assembly
and Viral Budding
Mutagenesis was performed to verify the biological relevance of
the conserved VP40 dimeric interface. Two mutations were
Figure 1. The Dimeric Structure of VP40
(A) A schematic of VP40 showing the location of
the N-terminal 43 residue deletion in VP40SDN
and VP40EDN and the NTD (blue) and CTD
(orange).
(B) The VP40EDN dimeric crystal structure is dis-
played with the NTDs from each protomer colored
light or dark blue and the CTDs colored light or
dark orange.
(C) The VP40EDN dimeric interface displaying
residues A55, H61, F108, A113, and M116 (green)
and L117 (yellow). The surface representation on
the light blue protomer illustrates how L117 rea-
ches into the opposing protomer.
See also Figures S1 and S2.made, L117R and T112R (VP40EDN-L117R and VP40EDN-
T112R), as modeling suggested that the larger arginine side
chain in these positions would disrupt the VP40 dimeric interface
(Figure 2A). Indeed, purified VP40EDN-L117R and VP40EDN-
T112R are primarily monomeric but also assemble some RNA-
binding ring structures (Figure S1). Thus, the L117R and T112R
mutations have not disrupted the tertiary structure of the VP40
NTD, as a properly folded NTD is essential for ring assembly
(Gomis-Ru¨th et al., 2003).
Western blot analysis of cells transfected with WT-VP40E or
the mutants VP40E-L117R or VP40E-T112R showed that,
whereas WT-VP40E is successfully released from cells, both
mutants are retained within the cell (Figure 2B). Indeed, immuno-
fluorescence analysis (IFA) illustrated that WT-VP40E efficiently
buds virus-like particles (VLPs), whereas both VP40E-L117R
and VP40E-T112R mutants fail to migrate to the membrane or
bud VLPs (Figure 2C). The IFA also indicated that VP40E-
T112R has a propensity to form perinuclear inclusions reminis-
cent of previously observed globular structures formed by
VP40 oligomeric rings (Panchal et al., 2003). Transmission elec-
tron microscopy (TEM) further showed that, whereas WT-VP40
assembles into filamentous VLPs and buds from the cell mem-
brane, both VP40E-L117R and VP40E-T112R fail to bud and
display no signs of assembly at the cell surface (Figure 2D).Cell 154, 763–774Thus, the L117R and T112R point muta-
tions disrupt VP40 dimer formation,
cellular trafficking, matrix assembly, and
budding of ebolavirus-like particles
but do not appear to impede the for-
mation of VP40 ring oligomers (Figures
2D and S1).
VP40 Dimers Further Assemble
End-to-End into Filaments that Are
Essential for Matrix Assembly and
Budding
In all crystal structures of VP40 containing
its C-terminal domain, the VP40 dimers
further assemble end-to-end into fila-
ments through homologous interactions
between their C-terminal domains (Fig-
ure 3A and S3). This primarily hydropho-bic CTD-to-CTD interface involves residues L203, I237, M241,
M305, and I307 and has a smooth topology along the buried
surface. The lack of interdigitation along this hydrophobic inter-
face potentially allows for torsional motion between the CTDs.
Indeed, potential motion about this interface can be observed
in the P62 crystal packing of VP40EDN, in which every other
dimer is rotated by 90 along this CTD-to-CTD interface
(Figure S3).
Mutagenesis was performed to determine whether the CTD-
to-CTD interface was relevant to ebolavirus matrix assembly
and formation of filamentous VLPs. Residue M241 is buried in
the CTD-to-CTD interface but is not integral to the fold of the
CTD. Modeling suggested that replacement of M241 with argi-
nine would impair formation of the CTD-to-CTD interface but
would not disrupt VP40 dimerization (Figure 3A). Indeed, purified
VP40EDN-M241R remains primarily dimeric in solution (Fig-
ure S1), yet transfected VP40E-M241R does not assemble or
bud filamentous VLPs (Figure 3B). The neighboring residue
T242, unlike M241, is solvent exposed and does not contribute
to the CTD-to-CTD interface. Hence, a control mutant, VP40E-
T242R, was also generated to ensure thatmerely placing an argi-
nine residue in this region of the CTD does not inhibit the function
of VP40. As anticipated, VP40E-T242R successfully assembles
and buds VLPs at wild-type levels (Figure 3B)., August 15, 2013 ª2013 Elsevier Inc. 765
Figure 2. Analysis of the VP40 Dimeric Inter-
face
(A) A dashed box displays a close-up view of the
dimeric interface, centered on residues T112 and
L117 (yellow). The point mutations T112R and
L117R have been modeled onto the structure
(black).
(B) Western blot of cell lysates and purified VLPs
from transfected cells. VP40E-L117R and VP40E-
T112R do not bud VLPs from transfected cells (red
arrows).
(C) IFA experiments show thatWT-VP40E localizes
to the cell membrane and buds VLPs (yellow
arrows), whereas both VP40E-L117R and VP40E-
T112R fail to localize to themembrane or assemble
and bud VLPs. VP40E-T112R also forms peri-
nuclear structures (orange arrow).
(D) EM micrographs display active VLP assembly
and budding from cells transfected with WT-
VP40E, whereas EM micrographs of cells trans-
fected with either VP40E-L117R or VP40E-T112R
display no assembly or VLP budding activity. Scale
bars, 500 nm.Interestingly, cells transfected with VP40E-M241R exhibit an
exaggerated membrane-ruffling morphology, indicating that
VP40E-M241R migrates to and interacts with the cell membrane
but still fails to properly assemble the matrix and bud VLPs. This
suggests that VP40E-M241R may assemble some intermediate
or defective matrix structure along the membrane (Figures 3C
and 3D). In order to determine how VP40E-M241R might be
assembling, we determined a crystal structure of the mutant.
Crystals of VP40EDN-M241R belong to the space group
P41212 and diffract to 4.15 A˚. The VP40EDN-M241R structure in-
dicates the VP40 dimer is intact, but interactions along the CTD-
to-CTD interface are limited by the M241R mutation. Within the766 Cell 154, 763–774, August 15, 2013 ª2013 Elsevier Inc.crystal packing, VP40EDN-M241R fails
to assemble any filaments and only inter-
acts with one neighboring dimer via a
minimal and twisted CTD-to-CTD inter-
face, with L203 and I307 at the center
rather than M241 (Figure S3). This may
explain why VP40E-M241R ruffles the
cell membrane but fails to bud VLPs, as
the M241R mutation allows for a limited
assembly of dimers to initiate membrane
curvature but fails to complete assembly
of the matrix to bud VLPs.
A Second Point Mutation in the
VP40 CTD-to-CTD Interface
Automatically Triggers Oligomeric
Ring Formation and RNA Binding
Residue I307, similar to M241, is also
buried in the CTD-to-CTD interface and
wasmutated to arginine in order to further
investigate the physiological relevance
of that interface (Figure 3A). Curiously,
the purified VP40EDN-I307R mutantdisplays a unique phenotype, in that it does not yield the
expected dimers but instead exclusively forms RNA binding olig-
omeric rings (A260/280 > 1.0) (Figures S1 and S4).
Western blots of cells transfected with VP40E-I307R indicated
that this mutation blocks assembly and budding of VLPs into the
supernatant (Figure 3B). Further, IFA showed that, in these cells,
VP40E-I307R does not migrate to the cellular membrane but
instead assembles into large globular structures around the nu-
cleus (Figure 3C). These perinuclear assemblies are similar to
those formed by VP40E-T112R (Figure 2C) and other ring-form-
ing VP40 mutants (Panchal et al., 2003). A control mutant analo-
gous to VP40E-T242R was also generated: VP40E-Q309R.
Figure 3. Analysis of the VP40 CTD-to-CTD Interface
(A) The CTD-to-CTD interface between VP40 dimers is shown with the NTDs from each protomer colored light or dark blue and the CTDs colored light or dark
orange. Below: a view of the CTD-to-CTD interface around residuesM241 and I307 (yellow), with the disruptivemutationsM241R and I307R (black) modeled onto
the orange CTD.
(B) Western blot of cell lysates and purified VLPs from transfected cells. Disruptive CTD-to-CTD interface point mutants, VP40E-M241R, VP40E-I307R, and
VP40E-R134A/I307R, fail to bud VLPs (red arrows). The CTD control mutants, VP40E-T242R and VP40E-Q309R, successfully assemble and bud VLPs.
(C) IFA of transfected cells shows that dimeric WT-VP40E and VP40E-R134A migrate to the cell membrane and bud VLPs (yellow arrows). In contrast, VP40E-
M241R and VP40E-R134A/I307R, bearing point mutations to the CTD-to-CTD interface, similarly migrate to the cell membrane but do not bud VLPs. Patches of
VP40E-R134A/I307R accumulated at the membrane are indicated by blue arrows. VP40E-I307R, which exclusively forms rings, does not migrate to the
membrane but rather forms perinuclear structures.
(D) EM micrographs show that WT-VP40E and VP40E-R134A cause typical membrane ruffling, assembly, and budding of filamentous VLPs (black arrows).
VP40E-M241R displays an exaggerated wild-type VP40 membrane-ruffling morphology, yet the cell surface remains devoid of budding filamentous VLPs.
VP40E-I307R and VP40E-R134A/I307R display no membrane ruffling, matrix assembly, or budding activity. Solid scale bars, 1 mm; dashed scale bars, 500 nm.
See also Figures S3 and S4.
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Residue Q309 is in close proximity to I307 but is solvent exposed
like T242, rather than buried in the CTD-to-CTD interface. As
expected, cells transfected with VP40E-Q309R assemble and
bud ebolavirus VLPs at wild-type levels (Figure 3B).
A different VP40 mutation, R134A, has been previously shown
to eliminate binding of RNA, disrupt formation of VP40 rings, and
yield wild-type VLPmorphologies and levels of budding (Hoenen
et al., 2005). Here, we show that purified VP40EDN-R134A
remains a dimer and confirm that VP40E-R134A assembles
and buds VLPs at wild-type levels (Figures 3 and S1). We next
generated a double mutant, VP40E-R134A/I307R, in which the
I307R component would prevent CTD-mediated filament
assembly and the R134A component would prevent I307R-
induced RNA binding and ring formation. As anticipated, purified
VP40EDN-R134A/I307R mutant is a nucleic-acid-free dimer in
solution (A260/280 < 0.6) (Figure S1). When transfected, VP40E-
R134/I307R no longer forms perinuclear inclusions. Instead, it
migrates to the cellular membrane, consistent with a dimeric
VP40 phenotype (Figure 3C). Although VP40E-R134A/I307R is
a membrane-trafficking dimer, it does not assemble or bud
VLPs (Figure 3), consistent with disruption of the CTD-to-CTD
interface by I307R. However, unlike cells transfected with
VP40E-M241R, cells transfected with VP40E-R134A/I307R are
devoid of membrane ruffles (Figure 3D). Modeling suggests
that, unlike M241R, the VP40E-I307R point mutation would
strictly prohibit any CTD-to-CTD interactions. Thus, the lack of
membrane ruffling is likely due to the inability of dimeric
VP40E-R134A/I307R to further assemble via the CTD along the
membrane.
Taken together, these results indicate that targeted mutations
to the CTD-to-CTD interface (M241R and I307R) block matrix
assembly and budding, whereas similar control mutations to
nearby residues in the CTD not directly involved in the CTD-to-
CTD interface (T242R and Q309R) have no effect on matrix
assembly and budding. Thus, the CTD-to-CTD interface, by
which VP40 dimers further assemble into filaments, appears
essential for matrix assembly and budding. In contrast, the
RNA-binding ring structures formed by VP40E-I307R do not
migrate to the membrane, assemble the viral matrix, or bud
VLPs. Currently, how the I307R mutation triggers VP40 ring for-
mation or howwild-type VP40 transitions into a ring during infec-
tion remain unknown.
A Conserved Basic Patch in the VP40 CTD Is Essential
for Assembly and Budding of Virus-like Particles
It has been previously shown that the C-terminal domain of VP40
is essential for electrostatic membrane interactions (Ruigrok
et al., 2000). We hypothesized that basic residues in the CTDs
of VP40 dimers were likely important for interacting with the
negatively charged cytoplasmic leaflet of the cell membrane.
We identified a basic surface on the VP40 CTD that is uniformly
exposed on a single side of the VP40 dimer surface (Figure 4A).
This basic patch is composed of six lysine residues (K221, K224,
K225, K270, K274, and K275) and is conserved across the five
distinct ebolaviruses (K225 is the one exception; it is R225 in
Bundibugyo virus). We first targeted K224 and K225, as they
reside in a flexible ten-residue loop that projects out from the
CTD basic patch (disordered in all crystal structures of VP40).768 Cell 154, 763–774, August 15, 2013 ª2013 Elsevier Inc.Initially, we deleted the loop entirely, generating the mutant
VP40E-D221-229, and found that although expression levels
and the dimeric structure were maintained, budding was abro-
gated (Figures S1 and S5). We next returned only the residues
223–226 (GKKG), generating VP40E-DGKKGD, in which resi-
dues 221–222 and 227–229 remained deleted. The restoration
of just theGKKGcomponent to VP40 restoredwild-type budding
activity (Figure 4C). To determine whether it was the electrostatic
charge of the KK motif that was important, we generated three
mutants: VP40E-DGMMGD (neutral charge, similar in structure
to lysine), VP40E-DGEEGD (negative charge), and VP40E-
DGRRGD (positive charge). Only cells transfected with VP40
containing positively charged residues at positions 224 and
225 were able to efficiently assemble and bud VLPs (Figure 4).
By contrast, cells transfected with VP40-DGEEGD or VP40-
DGMMGD display a failure to properly interact with the mem-
brane or bud VLPs (Figures 4C and 4D). These results suggest
that the positive charge in positions 224 and 225 of the GKKG-
containing loop is essential to proper membrane interactions,
matrix assembly, and budding of virus-like particles.
To further confirm the involvement of this CTD basic patch
in assembly, we mutated a second pair of conserved basic
residues, K274 and K275, to yield VP40E-K274R/K275R (con-
serves positive charge) and VP40E-K274E/K275E (replaces
with negative charge). As anticipated, VP40E-K274R/K275R
buds at wild-type levels, whereas VP40E-K274E/K275E fails to
bud any VLPs (Figure 4B). Interestingly, in contrast to VP40E-
DGMMGD and VP40E-DGEEGD, VP40E-K274E/K275E clearly
interacts with the cell membrane (Figure 4C) while displaying
no matrix assembly activity at the cell surface (Figure 4D). The
absence of any membrane ruffling by VP40E-K274E/K275E, in
contrast to VP40E-M241R (Figure 3D), suggests that electro-
static interactions of VP40 with the cellular membrane may
trigger a critical step in VP40 matrix assembly. This mechanism,
which involves further VP40 oligomerization upon interaction
with the membrane to drive matrix assembly and VLP budding,
is consistent with previously published work (Adu-Gyamfi
et al., 2013; Scianimanico et al., 2000).
Together, these results indicate that the conserved CTD basic
patch is essential to membrane interactions and for triggering
assembly of VP40 into the viral matrix to bud nascent virions.
Additionally, the importance of the CTD basic surface indicates
the most probable orientation and surface by which dimeric
VP40 interacts with the cellular membrane.
A Crystal Structure of Hexameric VP40 Reveals How
Dimers May Further Assemble into the Viral Matrix
It has previously been shown that VP40 undergoes conforma-
tional change at the plasma membrane, involving separation of
the N- and C-terminal domains (Adu-Gyamfi et al., 2013;
Gomis-Ru¨th et al., 2003; Scianimanico et al., 2000). Here, we
have shown that the NTD-to-NTD interface that assembles the
native VP40 dimer and the CTD-to-CTD interface by which
dimers further assemble are both essential for matrix assembly
and budding. However, these crystal structures were deter-
mined in the absence of phospholipids or electrostatically
negative mimics. Although these structures display the dimeric
interface, the CTD-CTD interface, and the basic surface that
Figure 4. Characterization of VP40 Basic
Patch
(A) Electrostatic surface potential of the VP40EDN
dimer in two orientations. The dimer interface is
indicated by a dashed line, and the division of the
NTD and CTD is depicted by a solid black line. The
attachment points of the disordered GKKG loop
are indicated by stars, and the loop is modeled as
a broken blue line (on right).
(B) Western blot of cell lysates and purified VLPs
from transfected cells. The VP40E-DGMMGD,
VP40E-DGEEGD, and VP40E-K274E/K275E con-
structs express, but fail to assemble or bud VLPs
(red arrows).
(C) IFA demonstrates that VP40E-DGKKGD and
VP40E-DGRRGD assemble and bud VLPs (yellow
arrows). By contrast, VP40E-DGEEGD and
VP40E-DGMMGD do not interact as well with
membrane and do not bud VLPs. Whereas VP40E-
K274E/K275E clearly migrates to and interacts
with the cell membrane, it fails to assemble and
bud VLPs.
(D) EM micrographs display active VLP assembly
and budding for VP40E-DGKKGD and VP40E-
DGRRGD but no assembly or VLP budding for
VP40E-DGEEGD, VP40E-DGMMGD, or VP40E-
K274E/K275E. Scale bars, 500 nm.
See also Figure S5 and Movie S1.are all critical tomatrix assembly (Figures 2, 3, and 4), they do not
account for the rotation of the CTD away from the NTD that is
thought to occur at the cell membrane (Gomis-Ru¨th et al.,
2003; Scianimanico et al., 2000).Wewondered how electrostatic
interactions with the membrane would affect VP40 structure and
assembly. Thus, we made a series of attempts to electrostati-
cally satisfy the positively charged elements of the CTD basic
patch by screening crystal conditions in the presence of various
negatively charged additives. We found success when using
dextran sulfate (Mr = 5 kDa) as an additive. Of particular rele-
vance, negatively charged dextran sulfate has been shown to
outcompete binding of similarly charged phosphatidylserine, a
known ligand of VP40 in the cell membrane (Ruigrok et al.,
2000; Zscho¨rnig et al., 1993).
VP40EDN crystals grown in the presence of dextran sulfate
belong to the space group P4212 and diffract to 3.5 A˚ with three
VP40 protomers (one and a half dimers) in the ASU. A crystallo-
graphic 2-fold axis lies along the VP40 dimer interface, joining
the ‘‘half dimer’’ at the end of one ASU to the ‘‘half-dimer’’ atCell 154, 763–774the start of the neighboring ASU to
assemble a complete dimer. Thus, the
biologically relevant unit present in these
crystals is a hexameric structure com-
prised of three VP40 dimers (Figure 5).
At each end of the hexamer is a VP40 pro-
tomer with its NTD and CTD in similar
arrangement to those previously crystal-
lized (Figure 5A). The remaining four
VP40 protomers in the center of the hex-
amer have undergone conformational
changes that have separated their N-and C-terminal domains. The NTDs of these four protomers
derive the central core of the hexamer and assemble through
an interface that we refer to as the ‘‘oligomerization interface’’
(Figure 5A). This oligomerization interface is homologous to the
‘‘antiparallel dimer’’ interface previously observed in the context
of the VP40 RNA-binding ring crystal structure (Gomis-Ru¨th
et al., 2003). The oligomerization interface is centered on residue
W95 and is revealed only through conformational displacement
of the CTD away from the NTD (Figure 5B). After the conforma-
tional changes, the four CTDs extend out from the central core
VP40 protomers in opposing directions (half are ‘‘up’’ and half
are ‘‘down’’). Electron density for the central core VP40 proto-
mers is only observable for the NTDs, as the ‘‘sprung’’ CTDs
linked to these NTDs now extend into large solvent channels in
the crystal packing and are disordered (Figure 5C). In the crystal,
the VP40 hexamers also further assemble into uninterrupted fila-
mentous structures via the same CTD-to-CTD interface
described above (Figure 3), through the ‘‘unsprung’’ CTDs of
adjacent ASUs (Figure 5C)., August 15, 2013 ª2013 Elsevier Inc. 769
Figure 5. Hexameric VP40 Crystal Structure
(A) The VP40EDN hexamer structure assembled
across a crystallographic 2-fold axis (red oval) is
illustrated with the NTDs alternating in colors of
light or dark blue, and the CTDs alternate in light or
dark orange. The NTDs and CTDs are numbered
according to the protomer to which they belong.
The disordered ‘‘sprung’’ CTDs are modeled as
circles (to scale). Below: a 90 rotation in which the
dimeric and oligomeric interfaces are indicated by
yellow and green lines, respectively.
(B) The oligomerization interface is displayed from
the VP40 hexamer and is centered on residueW95
(yellow).
(C) A section of the VP40EDN hexamer crystal
packing is shown; the NTD is colored blue; and the
CTD is colored orange. Here, the uninterrupted
filament structures formed via the CTD-to-CTD
interface (one filament indicated by a red line) as
well as the large solvent channels that contain the
‘‘sprung’’ CTDs can be seen.The observed filaments assembled from the VP40 hexamer
provide a compelling model for ebolavirus matrix assembly, as
they combine all of the biologically relevant VP40 surfaces and
interfaces shown to be critical to matrix assembly: (1) the NTD-
to-NTD dimeric interface involving L117 and T112 (Figure 2), (2)
the CTD-to-CTD interface involving M241 and I307 (Figure 3),
(3) the conserved membrane-interacting CTD basic patches ori-
ented along one single surface of the assembled filament (Fig-
ures 4 and S6), and (4) the ‘‘oligomerization interface,’’ by which
the NTDs assemble the central core of the hexamer (Hoenen
et al., 2010a).
The RNA-Binding VP40 Octameric Ring Plays a Distinct
Role in the Viral Life Cycle
Previous work demonstrated that VP40 is capable of assembling
an RNA-binding ring and that binding of RNA by VP40 is vital to
the ebolavirus life cycle (Gomis-Ru¨th et al., 2003; Hoenen et al.,
2005). Previous work also suggested that RNA may be essential
to forming or maintaining the VP40 ring structure (Timmins et al.,
2003). Here, however, we obtained a crystal structure of an RNA-770 Cell 154, 763–774, August 15, 2013 ª2013 Elsevier Inc.free octameric VP40 ring. This RNA-free
ring resulted from degradative loss of the
CTDs within a crystal drop that originally
contained purified RNA-free (A260/280 <
0.6), dimeric VP40EDN (Figure 6). These
crystals belong to the space group P422
and diffract to 1.85 A˚. The RNA-free ring
is nearly identical to the previously deter-
mined RNA-bound ring (Gomis-Ru¨th
et al., 2003), and both are assembled by
the same interfaces: the oligomerization
interface, also observed in the VP40 hex-
amer, and another interface unique to the
VP40 ring structure, which we term the
‘‘RNA-binding interface’’ (Figure 6A).
The RNA-free ring structure demon-
strates that RNA is not structurally neces-sary to stabilize or assemble the VP40 ring. However, in order
to verify whether RNA-free VP40 rings can assemble outside
of a crystal, we generated two VP40 CTD deletion constructs:
VP40EDCTD and VP40EDCTD-R134A. Purified VP40EDCTD
binds RNA (A260/280 > 1.0) and displays a size-exclusion chro-
matography elution profile consistent with formation of oligo-
meric rings in solution and with previous work (Gomis-Ru¨th
et al., 2003). The R134A point mutation prevents RNA binding,
and as anticipated, purified VP40EDCTD-R134A is RNA-free
(A260/280 < 0.6). However, its size-exclusion profile is consistent
with that of VP40EDCTD, demonstrating formation of RNA-free
rings in solution (Figure S1). Taken together, RNA is likely critical
to the displacement of the CTD from the NTD to trigger assembly
of the ring structure and is not necessary for the stability of the
NTD-formed ring structure itself.
There is one consistent structural difference that appears to be
critical to the formation of the VP40 octamer versus the VP40
dimer and hexamer. As observed both here and previously (Go-
mis-Ru¨th et al., 2003), the N-terminal 69 residues of VP40 need
to move out of the dimeric interface in order for ring formation
Figure 6. Analysis of the Octameric VP40
Ring Structure
(A) Crystal structure of the RNA-free VP40 octa-
meric ring, with alternating NTD protomers colored
in light and dark blue. Residue R134 is depicted
by yellow spheres. The oligomeric interface and
RNA-binding interface are indicted by green and
pink lines, respectively.
(B) The VP40EDN dimer. Opposing NTDs are
colored light or dark blue, and the CTDs are
colored light or dark orange. Residues 45–70 in the
dimer interface are colored red.
(C) By alignment of the NTDs from dimeric VP40
and RNA-bound VP40, we have modeled residues
45–70 ordered in the dimer (red) onto the RNA-
binding interface. The alignment demonstrates
how assembly of the RNA-binding interface would
be obstructed unless residues 1–70 unraveled
from the NTD structure.
(D) Minigenome reporter assays were performed in
triplicate, and data were normalized to a positive
control, expressing Renilla Luciferase to reflect
transcription levels of 100%. WT-VP40E reduces
transcription by 70%. Error bars represent the
SD of 3.7%, and VP40E-I307R reduces tran-
scription by 80% (SD = 2.6%). In contrast,
VP40E-R134A/I307R and VP40E-L117R only
reduce levels of transcription by 30% (SD =
3.3%) and 20% (SD = 5.3%), respectively.
See also Movie S2.to occur (Figure 6B). This conformational change likely destabi-
lizes the dimeric interface and exposes the RNA-binding
interface (Figure 6C). Importantly, previous work—showing the
presence of VP40 rings in ebolavirus-infected cells (Gomis-
Ru¨th et al., 2003)—and our full-length VP40E-I307R mutant,
which exclusively assembles VP40 rings, demonstrate that these
conformational changes also occur in the context of full-length
VP40.
The precise role of the VP40 RNA-binding ring in the viral life
cycle has yet to be elucidated. Data presented here indicate
that ring-forming VP40 does not traffic to the membrane and is
not required to bud VLPs (Figure 3). It has been suggested that
the RNA-binding VP40 ring likely has a critical role outside virion
assembly (Gomis-Ru¨th et al., 2003; Hoenen et al., 2005),
possibly in negative regulation of viral transcription (Hoenen
et al., 2010b). The discovery that our VP40E-I307Rmutant exclu-
sively assembles into rings allows us to unambiguously study the
function of the full-length VP40 ring oligomer in the cell using
ebolavirus minigenome reporter assays (Figure 6D). Consistent
with previous studies, we find WT-VP40E reduces transcription
by 70% compared to our normalized control (Hoenen et al.,
2010b). Further, we find our VP40E-I307R ring-only mutant
reduces viral transcription by 80%. Thus, VP40 locked intoCell 154, 763–774the ring structure can entirely recapitulate
the transcriptional control function. Next,
to determine whether RNA binding by
VP40 is critical to the observed reduction
in transcription, we repeated the experi-
ment with a double mutant incapable ofRNA binding, VP40E-R134A/I307R, and only observed a
30% reduction in transcription signal. Therefore, the RNA-
binding activity of the VP40 ring structure is critical to the
regulation of viral transcription observed with WT-VP40E and
VP40E-I307R.
Because regulation of viral transcription is not directly linked
to the dimeric structure of VP40, we were able to use the mono-
meric VP40E-L117R mutant to test whether dimeric VP40 is the
precursor structure to the RNA-binding ring. If VP40 exists as a
monomeric precursor, then assembly of the RNA-binding VP40
ring should still occur (L117R would be surface exposed in both
monomer and ring), resulting in wild-type VP40 levels of tran-
scriptional regulation. However, VP40E-L117R displays only an
20% reduction in viral transcription, suggesting that dimeric
VP40 is a necessary precursor to binding of RNA and assembly
of the VP40 RNA-binding ring. This result is in agreement with a
previous study suggesting that dimeric VP40 may be a building
block of higher-molecular-weight oligomers (Timmins et al.,
2003).
In summary, the results here show that the VP40 ring structure
has a clear role in regulation of viral transcription through its
RNA-binding activity, a role that is critical to the ebolavirus life
cycle (Hoenen et al., 2005). Additionally, dimeric VP40 is an, August 15, 2013 ª2013 Elsevier Inc. 771
Figure 7. Model of the VP40 Matrix
(A) A cross-section of an ebolavirus virion is modeled by assembly of VP40
(NTD is colored blue; CTD is colored light or dark orange) into a multilayered
matrix as predicted by our hexameric crystal structure and by tomographic
studies (Beniac et al., 2012; Bharat et al., 2011). The black box on the cross-
section corresponds to the box at right containing a four-filament assembly. In
this model, the crystal structure of the hexamer-assembled filament forms the
core layer of thematrix. The basic patches of the hexamer CTDs are positioned
toward the outer membrane, and the ‘‘sprung’’ CTDs form the inner and outer
matrix layers.
(B) Four individual VP40 filaments derived from the assembly of VP40 hex-
amers are modeled to scale onto 2D averages of virion tomograms. Black/
white has been inverted for clarity in these images; white now corresponds to
VP40 density (adapted from Beniac et al., 2012).
See also Figure S6.important precursor not only tomatrix assembly but also to bind-
ing of RNA and assembly of the VP40 RNA-binding ring.
DISCUSSION
How VP40 assembles the viral matrix and achieves its multiple
roles in the ebolavirus life cycle has remained enigmatic. We
discovered that VP40 is not a monomer, but is instead dimeric772 Cell 154, 763–774, August 15, 2013 ª2013 Elsevier Inc.and that the dimeric structure of VP40 is a critical precursor to
matrix assembly and budding.
The VP40 dimer structure has a butterfly-like shape with a
conserved basic patch in the CTD that is exposed across a single
surface of the dimer. Removing the positive charge of residues
contained in the CTD basic patch abrogates assembly and
budding of VLPs. The essential nature of this patch, coupled
with the absence of a uniformly presented basic surface any-
where else on the VP40 dimer, suggests that the surface contain-
ing the CTD basic patches likely interacts with the negatively
charged cytoplasmic leaflet of the cellular membrane. Interest-
ingly, our basic patch mutants display different phenotypes in
our IFA experiments. The VP40-DGEEGD mutant appears to
migrate out from the nucleus toward the membrane but fails to
interact with the membrane, whereas the VP40E-K274E/K275E
mutant very clearly interacts with the cellular membrane. We hy-
pothesize that the projecting VP40 GKKG loop is likely critical to
initial interactions with and orientation of VP40 to the membrane.
We further hypothesize that, as the VP40 dimer aligns along the
membrane, residues K274 and K275 contact lipid and trigger
conformational changes needed to assemble the viral matrix
and bud nascent virions. This model is consistent with previously
reported data (Adu-Gyamfiet al., 2012; Ruigrok et al., 2000; Scia-
nimanico et al., 2000) and our micrographs formed by electron
microscopy (EM) that display a membrane-ruffling phenotype
with VP40E-M241R, but not with VP40E-K274E/K275E. These
observations suggest that electrostatic interactions between
the VP40 dimer and the membrane trigger a step in viral matrix
assembly.
We also showed that cocrystallization of VP40 with dextran
sulfate, a 5 kDa electrostatically negative mimic of the known
VP40 membrane ligand phosphatidylserine (Ruigrok et al.,
2000), triggers VP40 conformational rearrangements and
assembly of VP40 dimers into a linear hexameric structure (Fig-
ure 4). The process by which the VP40 hexamer structure
assembles likely involves multiple steps: (1) dimeric VP40
migrates to the membrane and interacts along the membrane
in a uniform fashion via the basic patches on the CTDs, (2)
VP40 dimers then begin to assemble with each other through
CTD-to-CTD interactions, and (3) a twisting motion is induced,
springing the CTD away from NTD to facilitate the antiparallel
assembly of VP40 dimers along the oligomerization interface
observed in the VP40 hexamer (Movie S1). Recently, VP40 was
shown to partially penetrate the cell membrane upon matrix as-
sembly (Adu-Gyamfi et al., 2013). A twisting motion could lend
the force needed to push the CTD into the cell membrane.
In crystals, the VP40 hexamers assemble into continuous fila-
ments via the conserved M241- and I307-containing CTD-CTD
interface (Figures 7 and S6). In this arrangement, hexameric
VP40 creates a filamentous multilayered assembly. A central or
core layer is derived from repeating VP40 hexamers. Two other
layers, sandwiching the core, are formed by the CTDs that spring
up or down from the four NTDs at the core of each hexamer. We
believe this arrangement may reflect how the filovirus matrix is
assembled. CTDs of VP40 are known to interact with both the
membrane on the outside of the virion and also the nucleocapsid
at the center of the virion. The crystal structure, in which CTDs
spring alternately up or down, explains how this could occur.
The ‘‘upper’’ layer of CTDs could interact with the viral mem-
brane, whereas the ‘‘lower’’ layer of CTDs could interact with
the viral nucleocapsid (Figure 7A).
Recent tomographic analysis of filovirus virions demonstrates
that VP40 indeed assembles into a multilayered matrix (Bharat
et al., 2011), reflected in our model. In tomography, density for
the outer layer may have merged a bit with the membrane; as
in biophysical studies, the CTDs are observed to partially pene-
trate themembrane. In tomography, a ‘‘space’’ between the core
matrix layer is observed; in our model, the N-terminal domains of
the hexamer-assembled core do not lie directly against the
membrane after conformational changes have occurred (Beniac
et al., 2012; Bharat et al., 2011). Rather, the outer layer is bridged
to the core layer by the flexible linkers of the CTDs, which are not
electron dense.
Further, as observed in tomographic studies, repeating struc-
tural features along the axis of the virion closely correspond to
repeating features observed in the VP40 hexamer: 5 nm (width
of NTD dimer) and7 nm (length of repeating ASUs in hexamer-
assembled filaments) (Beniac et al., 2012; Bharat et al., 2011).
Tomographic two-dimensional (2D) averages of the VP40 matrix
from ebolavirus suggest that the matrix has a somewhat flexible
and pleomorphic, but generally repeating structure (Beniac et al.,
2012). Individual VP40 filaments assembled by repeating hex-
amers in the crystal packing match the observed repeating den-
sity array in 2D averages from equivalent tomographic slices
(Figure 7B).
A remaining question is whether, in the actual viral matrix, all
CTDs have sprung and the central core is made only from
NTDs or whether the central core layer is assembled from
repeating hexamers at each end. We believe that CTD-CTD
interactions are likely involved in the core matrix layer. Only the
CTD-CTD interface provides a slippery, flexible surface. All
NTD-NTD interfaces visualized thus far are rigid. An NTD-only
filament, in the absence of any CTD-CTD interfaces contained
at any interval within it, would likely present a rigid, uniform struc-
ture, inconsistent with the flexible and pleomorphic nature of the
filovirus virion (Bharat et al., 2011; Beniac et al., 2012). Further,
our mutagenesis to the CTD (Figure 3) and previous work
demonstrating lipid-induced assembly of VP40 hexamers (Scia-
nimanico et al., 2000) suggest that CTD-to-CTD interactions and
discrete hexameric units, as are bounded by this interaction, are
both critical parts of the ebolavirus matrix structure.
Until now, the roles of RNA binding and the resulting VP40 ring
structures in the viral life cycle have remained elusive. This was
primarily due to the fact that studying VP40 ring formation in
the cell has previously required either truncating the CTD or uti-
lizingmutations that we now see affect all of dimer, octamer, and
hexamer. Here, the I307Rmutation allowed us to unambiguously
characterize the cellular function of full-length VP40 in its oligo-
meric ring state. We found that when VP40 is bound to RNA
and adopts the ring structure, it assumes a perinuclear location.
Moreover, our minigenome assays now demonstrate that bind-
ing of RNA by VP40 and the RNA-binding ring structure confer
the transcriptional control function. Recent studies demonstrate
that in the early stages of ebolavirus infection, VP40 first partic-
ipates in the formation of perinuclear structures with additional
viral proteins (Nanbo et al., 2013). Thus, we propose that VP40RNA binding is critical to the initial stages of viral transcription
upon infection. This is consistent with previous data that indicate
recombinant viruses with a VP40 RNA-binding knockout muta-
tion (R134A) fail to replicate (Hoenen et al., 2005). The mecha-
nism by which VP40 transitions from a dimer to a ring structure
during an infection remains elusive and is the topic of continued
investigation. Although RNA is not required to form a ring from
CTD-deleted VP40, it may play a role in displacement of NTD
and CTD from each other in natural infection. A hypothesis for
how dimeric VP40 transitions into the ring structure is modeled
in Movie S2.
The results presented here and previously (Timmins et al.,
2003) illustrate how the VP40 protein performs multiple distinct
roles in the ebolavirus life cycle. Through structural rearrange-
ments, VP40 assembles multiple distinct structures with unique
and essential functions. It is known that viral proteins are multi-
functional, but our work on VP40 calls into question the belief
that a single viral protein structure or assembly is responsible
for all of the known functions of that protein. Viruses, particularly
RNA viruses, can be subject to limitations on genomic size. By
encoding proteins that can structurally rearrange themselves to
operate at different stages of the life cycle, viruses like the ebola-
viruses can accomplish a multitude of essential functions with a
limited number of genes. Further, other viral matrix proteins,
such asM of respiratory syncytial virus andM1 of influenza virus,
are also constructed via discreteNTDs andCTDs connected by a
long linker, bind RNA, and regulate viral transcription (Baudin
et al., 2001; Money et al., 2009). Hence, other viruses may
encode proteins capable of similar structural transformations.
The structure-shifting properties of VP40 provide additional
opportunities for the development of antiviral drugs. For
example, small molecules capable of influencing the propensity
of one VP40 structure over another (as seen with VP40E-I307R)
could severely impede the ebolavirus life cycle. VP40 thus pro-
vides a model for how viruses with small genomes, like ebolavi-
ruses, can accomplish a multitude of essential functions with a
limited number of proteins.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
VP40SDN and VP40EDN (and VP40EDN mutants) were expressed in BL-21
Rosetta 2 Escherichia coli cells using the pET-46 Ek/LIC vector. For details,
see the Extended Experimental Procedures.
Western Blots
293 cells were transfected with a pTRIEX 5 plasmid expressingWT-VP40E or a
mutant VP40E. Analysis was carried out 24 hr posttransfection. For details, see
the Extended Experimental Procedures.
Confocal Microscopy
293 cells were transfected with a pCAGGS plasmid expressingWT-VP40E or a
mutant VP40E. Analysis was carried out 24 hr posttransfection. For additional
details, see the Extended Experimental Procedures.
Other methods are described in the Extended Experimental Procedures.
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